An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)

NCT01697462 · clinicaltrials.gov ↗
COMPLETED
Status
258
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche